Bruce Sachais
Program Director · Cornell Univ Joan and Sanford I Weill Med Coll
Credentials: · · · · ·
History
- 1996–2000
Pathology
- 1992–1996
Doctor of Medicine
Research
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Review · Journal of Clinical Investigation · 2020 · 573 citations
Blood · 2005 · Last of 9 authors · 226 citations
Nature Medicine · 2021 · 216 citations
23 papers
13 papers
8 papers
- MC
8 papers
7 papers
7 papers
6 papers · 6 as a resident
6 papers
Grants
- 2014–2019
Small Molecule Antagonists of pf4 for the Treatment and Prevention of Hit
National Heart, Lung, and Blood Institute · R42
Contact PI · $1.9M · Fox Chase Chemical Diversity Center, Inc
- 2014–2016
Small Molecule Antagonists of PF4 for the Treatment and Prevention of HIT
National Heart, Lung, and Blood Institute · R41
Contact PI · $225K · Fox Chase Chemical Diversity Center, Inc
- 2002–2014
Transfusion/Hemostasis Clinical Research Network
National Heart, Lung, and Blood Institute · U01
Contact PI · $418.8K · University of Pennsylvania
- 2006–2012
Proatherogenic Properties of Platelet Fator 4
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.1M · University of Pennsylvania
Clinical trials
- 2010
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Principal investigator · Completed
Carelon Research
- 2010–2013
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Principal investigator · Terminated · Phase 3
Carelon Research
- 2008–2013
Principal investigator · Completed · Phase 3
Carelon Research